
zzso obesity is associated with various cardiovascular disorders, including diabetes, zzso and zzso zzso with zzso agents is an important management strategy in conjunction with lifestyle zzso 

This article describes the zzso management of zzso concentrating on zzso and zzso 

zzso articles were identified through a zzso search zzso 2002) using the terms zzso overweight, weight loss, zzso drugs, zzso and zzso The search for efficacy trials was limited to zzso controlled studies zzso months' zzso Also included in the review were relevant references cited in the zzso of identified articles, news reports, and the zzso own zzso 

zzso reduces fat zzso by zzso gastrointestinal zzso In randomized, controlled trials of up to 2 years' zzso zzso plus a zzso diet produced significantly greater weight loss than zzso zzso zzso In the maintenance phase, patients taking zzso had less weight regain than did zzso zzso The weight reduction with zzso was also associated with a significant improvement in control of cardiovascular risk factors zzso zzso Unlike zzso zzso works by suppressing zzso its zzso however, was similar to that of zzso in the identified clinical zzso zzso was associated primarily with gastrointestinal side zzso Use of zzso was associated with minimal drug zzso except with zzso with which it should not be zzso zzso was also well zzso although it may cause dry mouth, zzso and insomnia, and should be used with caution in patients at risk for cardiovascular zzso 

zzso and zzso demonstrated a favorable efficacy and safety profile in zzso controlled zzso Current evidence supports their use as zzso to lifestyle modifications in the treatment of zzso 

